Table 1 |
|
|
Patients' demographic data, clinical characteristics, and survival |
|
|
Demographic data |
|
|
|
|
|
Age in years, median (range) |
52 (25 to 73) |
|
Female/male, number |
10/10 |
|
Septic shock: reasons |
|
|
Pneumonia |
8 |
|
Urosepsis |
4 |
|
Cholangitis |
4 |
|
Endocarditis |
3 |
|
Catheter-associated |
3 |
|
Pathogen |
|
|
Staphylococcus epidermidis, number |
6 |
|
Staphylococcus aureus, number |
2 |
|
Haemophilus influenca, number |
4 |
|
Enterococcus faecalis, number |
3 |
|
Escherichia coli, number |
3 |
|
Pseudomonas aeruginosa, number |
2 |
|
Severity-of-illness scores |
|
|
APACHE II score, median (range) |
30 (18 to 52) |
|
SAPS II, median (range) |
42 (32 to 66) |
|
Catecholamine therapy |
|
|
Dobutamine, number Dose in μg/kg per minute (mean ± SD) |
20 (6.4 ± 2.9) |
|
Norepinephrine, number Dose in μg/kg per minute (mean ± SD) |
16 (0.2 ± 0.2) |
|
Outcome |
|
|
ICU mortality rate, number (percentage) |
4 (20) |
|
Hospital mortality rate, number (percentage) |
5 (25) |
|
|
|
|
APACHE, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unit; SAPS, Simplified Acute Physiology Score; SD, standard deviation. |
|
|
Link et al. Critical Care 2008 12:R159 doi:10.1186/cc7158 |
|
